Elite Rat Monoclonal Antibody Discovery Service

Background Technology Workflow Advantage Related Services FAQ Online Inquiry

Harnessing the unique immunological advantages of the rat system, Creative Biolabs delivers high-affinity, high-specificity Rat Monoclonal Antibodies (Rat mAbs) tailored for complex research, diagnostic, and therapeutic development applications. We have replaced traditional, time-consuming hybridoma techniques with our advanced, high-throughput phage display-based Rat Monoclonal Antibody discovery platform. By capitalizing on the construction and screening of immune antibody libraries, our service offers unparalleled speed, diversity, and flexibility. We deliver fully characterized monoclonal antibodies with exceptional performance, enabling breakthroughs in your most demanding projects.

Discuss Your Project Today

Introduction of Rat Monoclonal Antibodies

While the mouse has long been the workhorse for monoclonal antibody production, the rat model offers distinct and critical advantages that make it the superior choice for many applications. Researchers increasingly turn to Rat Monoclonal Antibody Discovery to overcome challenges where mouse models fall short.

Broader Epitope Recognition: The rat immune system often recognizes different epitopes on antigens compared to mice. This is especially valuable for highly conserved human or mouse proteins, where mice may exhibit immune tolerance. A Rat Monoclonal Antibody can often identify a novel functional epitope that a mouse antibody cannot.
Superior for Mouse-on-Mouse Studies: Using rat mAbs in mouse models (e.g., in vivo studies, IHC on mouse tissue) is a preferred strategy. It avoids the non-specific background binding and anti-isotype responses that plague mouse-on-mouse experiments, leading to cleaner data and more reliable conclusions.
Unique Isotype Properties: Rats possess a diverse set of antibody subclasses (e.g., IgG1, IgG2a, IgG2b, IgG2c) with distinct effector functions. Notably, rat IgG2c is an excellent complement-fixing antibody, making it ideal for complement-dependent cytotoxicity (CDC) assays and other functional screening applications.
Robust Immune Response: Rats are larger animals with a more robust immune system, often mounting strong responses to small molecules, haptens, and antigens that are poorly immunogenic in mice.

Our Premier Technology: Phage Display-Based Rat Monoclonal Antibody Discovery

Traditional rat hybridoma technology, while foundational, is notoriously inefficient, slow, and prone to cell line instability. Creative Biolabs has engineered a state-of-the-art solution: a fully in vitro platform centered on phage display and sophisticated immune antibody library technology.

This phage display-based Rat Monoclonal Antibody platform captures the complete, immunized B-cell repertoire of a rat and displays it on the surface of bacteriophages. This "library" becomes a renewable resource that can be screened against any target with exceptional precision and speed.

The Power of the Immune Antibody Library

Our process begins by leveraging the rat's in vivo affinity maturation. We perform hyper-immunization using your specific antigen. This crucial step pushes the B-cell response toward generating high-affinity antibodies. We then harvest the lymphocytes and utilize our expertise in the construction and screening of immune antibody library systems.

Repertoire Capture: We extract mRNA from the antibody-producing cells and reverse-transcribe it into a stable cDNA library.
V-Gene Amplification: Using a proprietary, optimized set of rat-specific primers, we amplify the variable heavy (VH) and light (VL) chain genes. This ensures the full diversity of the immune response is captured.
Library Construction: These V-genes are cloned into our advanced phagemid vectors, creating a vast immune antibody library where each phage particle displays a unique Rat Monoclonal Antibody fragment (ScFv or Fab) on its surface. A typical immune antibody library for Rat Monoclonal Antibody Discovery from Creative Biolabs contains over 10^8 - 10^11 unique clones, far exceeding the screening capacity of hybridoma fusion.

This method completely bypasses the inefficient cell-fusion step, eliminates the risk of unstable hybridoma cell lines, and allows for the rescue of valuable antibody genes from low-frequency B-cells that would be lost in a traditional workflow.

Our Streamlined Workflow for Rat Monoclonal Antibody Discovery

Creative Biolabs has optimized every step of the immune antibody library for Rat Monoclonal Antibody Discovery pipeline to ensure maximal efficiency, quality, and project speed.

Phase 1. Antigen & Immunization Strategy

Consultation: Our PhD-level experts consult with you to design the perfect antigen strategy (protein, peptide, DNA, whole cell).
Immunization: We use robust immunization protocols to elicit a potent, high-titer immune response.

Phase 2. Rat Immune Antibody Library Construction

Harvest: Spleen and lymph nodes are harvested from the hyper-immunized rat.
RNA/cDNA: Total RNA is extracted, and cDNA is synthesized.
V-Gene PCR: The complete repertoire of rat VH and VL genes is amplified.
Cloning & Transformation: The antibody fragments are cloned into our proprietary phagemid vector to generate the final immune antibody library. Library quality and diversity are confirmed by sequencing.

Fig. 1 Immune rat antibody library construction. (Creative Biolabs Authorized). Fig. 1 Rat Immunized Phage Display Library.

Phase 3. Biopanning & Screening

Panning: The phage display library is subjected to 3-4 rounds of biopanning against the immobilized target antigen. This affinity-based selection process enriches for high-affinity binders.
Screening: Individual phage clones are screened (e.g., phage ELISA) to identify a large panel of positive "hits."

Phase 4. Hit Characterization & Sequencing

Confirmation: Positive hits are confirmed by ELISA.
Sequencing: The VH and VL genes of all unique binders are sequenced. This provides the digital "genetic code" of your antibody, ensuring it is never lost.

Phase 5. Antibody Reformatting & Production

Reformatting: The most promising ScFv or Fab binders are reformatted into full-length IgG (or any desired rat/human isotype) in our high-expression mammalian vector system.
Production: We perform transient expression and purification to deliver highly pure, functionally active rat monoclonal antibodies.

Comprehensive Service Features for Rat Monoclonal Antibody Discovery

We provide an end-to-end solution, customized to your project goals.

Flexible Immunization & Library Strategies

Diverse Antigens: We have successful protocols for proteins, peptides (with proprietary carrier conjugation), small molecules, DNA, and even whole-cell immunizations.
Multiple Strains: Access to various rat strains (SD, Wistar, Lewis) to maximize immune repertoire diversity.
Custom Library Construction: We specialize in the construction and screening of immune antibody library systems tailored for your specific needs, including V_HH (sdAb) discovery if required.

Sophisticated Panning & Screening

Advanced Panning: We employ solid-phase, solution-phase, and cell-based panning strategies to isolate antibodies with specific functional properties (e.g., binders to cell-surface receptors).
Competition & Subtractive Panning: We can isolate antibodies that bind to specific epitopes, block a receptor-ligand interaction, or differentiate between highly similar protein isoforms.
High-Throughput Screening: Our platform integrates HTP-ELISA and flow cytometry screening to rapidly identify the best candidates from thousands of clones.

Downstream Engineering & Production

Full-Length Reformatting: Seamless conversion of positive hits (ScFv/Fab) into full-length rat IgG, human-rat chimeric IgG, or any other format.
Affinity Maturation: We can further improve the affinity of your lead candidates using our in vitro affinity maturation platforms.
Scalable Production: cGMP-compliant production of your final Rat Monoclonal Antibody from milligram to gram scales.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Don't let the limitations of traditional methods hold back your research. Contact Creative Biolabs today to leverage the speed, power, and diversity of our advanced phage display-based Rat Monoclonal Antibody platform.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: Why should I choose your phage display service over traditional rat hybridoma?

A: Our phage display-based Rat Monoclonal Antibody service is significantly faster, provides access to a much larger diversity, and is far more effective for difficult antigens (e.g., toxic, low immunogenicity). Furthermore, you receive the antibody's sequence, a permanent, stable digital asset, rather than a potentially unstable hybridoma cell line.

Q: What is the typical affinity of antibodies discovered from an immune library?

A: Because our platform starts with an immunized animal, we are capturing an in vivo matured B-cell repertoire. The resulting antibodies typically have high affinities, often in the sub-nanomolar range, which is ideal for demanding applications.

Q: What types of antigens can you handle for the Rat Monoclonal Antibody Discovery service?

A: Our platform is extremely versatile. We routinely work with purified proteins (recombinant or native), peptides, DNA, and complex antigens like whole cells or membrane preparations. Our phage display technology is particularly well-suited for targets that are toxic to cells, as the entire selection process is in vitro.

Q: Can you discover antibodies against a specific epitope or functional site?

A: Yes. We can design highly specific panning strategies. This includes "competition panning," where we use a known ligand or antibody to block a site, forcing the selection of antibodies that bind to other epitopes. We can also perform subtractive panning to remove antibodies that cross-react with a related protein, ensuring high specificity.

Q: What is the first step to starting a project?

A: Simply click "Get a Quote" or "Contact Us." You will be connected with one of our senior scientists to discuss your target, your research goals, and how our immune antibody library for Rat Monoclonal Antibody Discovery can be tailored to provide the perfect solution for you.

Reference

Tajima, Tetsuya, et al. "Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats." Frontiers in Immunology 14 (2023): 1186653. https://doi.org/10.3389/fimmu.2023.1186653

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.